The effects of interventional mitral valverepair with the MitraClip system on theresults of pulmonary function testing

• Conditions: I34.0; Mitral (valve) insufficiency

• Registration Number: DRKS00022435
• Lead Sponsor: Helios Klinikum Pirna

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-07-31
• Study Start: 2020-08-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All participants had to have the following characteristics (inclusion criteria): A) Men and women of any ethnicity aged at least 18 years; B) Indication for interventional mitral valve repair using the MitraClip device according to the current available evidence regarding this treatment; C) Ability to give an informed consent after oral and written information.

Exclusion Criteria

A) Simultaneous participation in other studies; B) Lack of informed consent to the evaluation of their personal and medical data.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim of the study is to show that treatment with the Mitraclip method can improve the diffusing capacity of the lung for carbon monoxide (DLCO) in 6 weeks of follow-up; In this study we conducted the DLCO measurement before the intervention and 6 weeks post-procedural using body plethysmography.

Secondary Outcome Measures

Name	Time	Method
efficacy